Sector consensus Grifols, S.A.

Equities

Real-time Estimate Tradegate Other stock markets 10:20:30 12/12/2025 GMT			5-day change	1st Jan Change
10.76 ^EUR	+0.59%		-0.05%	+17.46%

12-04	Grifols achieves self-sufficiency in plasma-derived medicines in Egypt	RE
12-03	European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
GRIFOLS, S.A.			€15.2	+42.06%	12
REGENERON PHARMACEUTICALS, INC.			US$782.86	+4.83%	26
CSL LIMITED			A$160.4	+34.58%	16
UCB			€264.67	+9.96%	18
SAMSUNG BIOLOGICS CO.,LTD.			₩2,203,354.67	+32.02%	25
BIOGEN INC.			US$179.93	+4.31%	29
INCYTE CORPORATION			US$99.62	+3.66%	21
INNOVENT BIOLOGICS, INC.			HK$99.89	+31.66%	25
ALTEOGEN INC.			₩522,000	+15.1%	5
INTRA-CELLULAR THERAPIES, INC.	-	-	-	-	-
BRIDGEBIO PHARMA, INC.			US$85.17	+14.99%	18
SWEDISH ORPHAN BIOVITRUM AB			SEK 367.09	+10.24%	11
MODERNA, INC.			US$35.47	+19.72%	19
AVIDITY BIOSCIENCES, INC.			US$74	+3.35%	11
BIOMARIN PHARMACEUTICAL INC.			US$88.48	+66.97%	25
3SBIO INC.			HK$34.74	+38.98%	11
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	-	CN¥50	+6.04%	1
AXSOME THERAPEUTICS, INC.			US$179.74	+20.83%	20
KRYSTAL BIOTECH, INC.			US$223	-9.63%	10
Average			151,560.83	+19.43%	17
Weighted average by Cap.			297,446.94	+18.36%	20